SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

News > France & Monaco

Please find below news from France and Monaco as well as about organisations from these countries.

Total search results: 1504 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sanofi S.A.. (10/12/17). "Press Release: Sanofi Invests €170 Million in New Vaccine Production Facility in France". Paris. 2017-10-12
Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe". 2017-10-11
Bryan, Garnier & Co., Ltd.. (10/10/17). "Press Release: Bryan, Garnier & Co Grows Its Equity Research Healthcare Team". Paris. 2017-10-10
Erytech Pharma. (10/10/17). "Press Release: Erytech Announces Resubmission of European Marketing Authorization Application for Graspa in Acute Lymphoblastic Leukemia". Lyon. 2017-10-10
Bryan, Garnier & Co., Ltd.. (10/9/17). "Press Release: Bryan, Garnier & Co Grows Its Healthcare Franchise with the Hiring of Dr Anne Moore". Paris. 2017-10-09
Erytech Pharma. (10/6/17). "Press Release: Erytech Files Registration Statement for Proposed Initial Public Offering in the United States". Lyon. 2017-10-06
Cellectis S.A.. (10/4/17). "Press Release: Mathieu Simon, M.D. Cellectis’ EVP & Chief Operating Officer, to Serve as Interim Chief Medical Officer". New York, NY. 2017-10-04
Servier. (10/4/17). "Press Release: Servier Opts for Saclay as Its Future Research Centre". 2017-10-04
Global Bioenergies S.A.. (10/3/17). "Press Release: Global Bioenergies Strengthens Its Management Team". Évry. 2017-10-03
Transgene S.A.. (10/2/17). "Press Release: Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors". Strasbourg & Belfast. 2017-10-02
Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. 2017-10-02
Abivax S.A.. (9/28/17). "Press Release: Abivax’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial". Paris. 2017-09-28
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
LNC Therapeutics. (9/27/17). "Press Release: LNC Therapeutics Raises € 6.5 Million and Reinforces Its R&D in the Microbiota Field". Bordeaux. 2017-09-27
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
Eligo Bioscience. (9/26/17). "Press Release: Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome". London. 2017-09-26
Transgene S.A.. (9/21/17). "Press Release: Transgene Launches Invir.IO¸, its Integrated Platform for the Next Generation of Multifunctional Oncolytic Viruses". Strasbourg. 2017-09-21
BioSerenity. (9/20/17). "Press Release: BioSerenity, Digital Health Champion, Raises 15 Million Euros". Paris. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax Receives French Regulatory Approval to Begin Clinical Trial of ABX464 in Ulcerative Colitis". Paris. 2017-09-20
Enterome S.A.. (9/20/17). "Press Release: Enterome to Move its Research Laboratories to Genopole, France’s First Biocluster". Évry. 2017-09-20
Transgene S.A.. (9/19/17). "Press Release: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers". Strasbourg. 2017-09-19
Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris. 2017-09-18
Transgene S.A.. (9/13/17). "Press Release: First Half-year 2017 in Line with Our Objectives – All Clinical Programs Progressing and New Collaboration Agreements Signed". Strasbourg. 2017-09-13
DNA Script. (9/12/17). "Press Release: DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology". Paris. 2017-09-12
Roche. (9/11/17). "Press Release: Onxeo Announces Top-line Results from ReLive Phase III Study of Livatag in Advanced Hepatocellular Carcinoma". Paris. 2017-09-11
Erytech Pharma. (9/11/17). "Press Release: Erytech Reports First Half 2017 Financial Results and Provides Business Update". Lyon. 2017-09-11
Transgene S.A.. (9/11/17). "Press Release: Transgene Receives FDA IND Approval to Begin a Clinical Trial with TG4010 + Nivolumab + Chemotherapy in the First-Line Treatment of Lung Cancer (NSCLC)". Strasbourg. 2017-09-11
Erytech Pharma. (9/8/17). "Press Release: Erytech Announces Positive Full Results from Phase 2b Study of Eryaspase in Combination with Chemotherapy for Treatment of Metastatic Pancreatic Cancer in Second-Line". Lyon. 2017-09-08
HalioDx S.A.S.. (9/8/17). "Press Release: HalioDx Announces Clinical Collaboration with PRODIGE to Evaluate Immunoscore in IDEA1 Stage III Colon Cancer Study". Marseille. 2017-09-08
IntegraGen S.A.. (9/7/17). "Press Release: IntegraGen Announces CE-IVD Marking of miRpredX 31-3p Kit which Predicts Patient Response to anti-EGFR Therapy in RAS Wild-Type Metastatic Colorectal Cancer". Évry. 2017-09-07
OSE Immunotherapeutics S.A.. (9/7/17). "Press Release: OSE Immunotherapeutics Reports on First-Half 2017 Financial Results and Provides Update on Clinical Advances of its Product Portfolio". Nantes. 2017-09-07
HalioDx S.A.S.. (9/7/17). "Press Release: HalioDx Participates in Two Grants-supported Academic Collaborations". Marseille. 2017-09-07
Medicen Paris Region. (9/7/17). "Press Release: BioWin and Medicen Focus on Developing Medical Imaging and Digital Health in Europe". Gosselies & Paris. 2017-09-07
Servier. (9/5/17). "Press Release: Servier and Institut Curie Extend Duration and Scope of Partnership in Fight against Cancer". 2017-09-05
Cellectis S.A.. (9/4/17). "Press Release: Cellectis Reports Clinical Hold of UCART123 Studies". New York, NY. 2017-09-04
bioMérieux S.A.. (8/30/17). "Press Release: First-Half 2017 Results". Marcy l’Étoile. 2017-08-30
Alimera Sciences, Inc.. (8/29/17). "Press Release: Alimera Sciences Signs Agreement for Exclusive Distributor of Iluvien in France". Atlanta, GA. 2017-08-29
DBV Technologies S.A.. (8/29/17). "Press Release: DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut". Montrouge. 2017-08-29
Sanofi S.A.. (8/28/17). "Press Release: Sanofi Completes the Acquisition of Protein Sciences". Paris. 2017-08-28
Servier. (8/24/17). "Press Release: WeHealth by Servier, Servier’s E-health Department, Teams Up with CardioRenal to Provide Better Support to Heart Failure Patients". 2017-08-24
Cellectis S.A.. (8/17/17). "Press Release: Cellectis’ UCART123 Administered to First Patient with BPDCN in Phase I Clinical Trial at MD Anderson Cancer Center". New York, NY. 2017-08-17
Nicox S.A.. (8/15/17). "Press Release: Nicox Announces €26.25 Million Financing [Not for distribution in or into the United States of America, Canada, Japan or Australia, except as permitted by applicable law]". Sophia Antipolis. 2017-08-15
Genkyotex S.A.. (8/3/17). "Press Release: Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts". Archamps & Geneva. 2017-08-03
DBV Technologies S.A.. (8/2/17). "Press Release: DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-allergic Patients One to Three Years of Age". 2017-08-02
Cellectis S.A.. (8/2/17). "Press Release: Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2017". New York, NY. 2017-08-02
Valneva S.E.. (8/1/17). "Press Release: Valneva Announces Expansion of its Management Board – Strengthening Senior Management for Future Growth". Lyon. 2017-08-01
GenSight Biologics S.A.. (8/1/17). "Press Relase: GenSight Biologics Completes Enrollment of RESCUE Phase III Study of GS010 in the treatment of Leber’s Hereditary Optic Neuropathy". Paris. 2017-08-01
GenSight Biologics S.A.. (7/28/17). "Press Relase: GenSight Biologics Reports Interim Financial Results for the First Half of 2017". Paris. 2017-07-28
Genkyotex S.A.. (7/27/17). "Press Release: Genkyotex Provides Business Update for Q2 2017". Archamps. 2017-07-27
TxCell S.A.. (7/26/17). "Press Release: TxCell – Financial Information for the 2nd Quarter of 2017". Valbonne. 2017-07-26
Cellectis S.A.. (7/25/17). "Press Release: Calyxt Announces Full Exercise of Over-allotment Option and Closing of Its Initial Public Offering". St. Paul, MN & New York, NY. 2017-07-25
Valneva S.E.. (7/24/17). "Press Release: Valneva Receives FDA Fast Track Designation for Its Lyme Disease Vaccine Candidate VLA15". Lyon. 2017-07-24
Cellectis S.A.. (7/24/17). "Press Release: Cellectis Granted Patent for CRISPR Use in T-Cells". New York, NY. 2017-07-24
Sanofi S.A.. (7/21/17). "Press Release: Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2017-07-21
bioMérieux S.A.. (7/20/17). "Press Release: Second-Quarter 2017 Business Review". 2017-07-20
Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge. 2017-07-20
GlaxoSmithKline plc. (7/20/17). "Press Release: ViiV Healthcare Shares Data from Its Innovative Portfolio with HIV Community at IAS 2017". London. 2017-07-20
OSE Immunotherapeutics S.A.. (7/19/17). "Press Release: OSE Immunotherapeutics Receives €9.2 Million Grant from Bpifrance “Invest in the Future Program” for Development of New Immune Checkpoint Inhibitor OSE-172 (Effi-DEM)". Nantes. 2017-07-19
Cellectis S.A.. (7/19/17). "Press Release: Calyxt Announces Pricing of $56.0 Million Initial Public Offering". St. Paul, MN & New York, NY. 2017-07-19
Enterome S.A.. (7/12/17). "Press Release: Enterome Appoints Mary Thistle to Its Board of Directors". Paris. 2017-07-12
Enterome S.A.. (7/11/17). "Press Release: Enterome and Nestlé Health Sciences Launch New Diagnostics Company". Paris. 2017-07-11
Cellnovo. (7/10/17). "Press Release: New Juncker Plan Transaction in France – Cellnovo Concludes a Loan Agreement for up to €20 Million from the European Investment Bank". Paris. 2017-07-10
Cellectis S.A.. (7/10/17). "Press Release: Calyxt Announces Proposed Initial Public Offering of $100.0 Million". St. Paul, MN & New York, NY. 2017-07-10
Cellnovo. (7/7/17). "Press Release: Cellnovo Successfully Raises €17.5 Million from Healthcare Investors [Not for Distribution in the United States of America, Canada, Australia and Japan]". 2017-07-07
Cellnovo. (7/6/17). "Press Release: Cellnovo Launches a Capital Increase for Approximately €15 Million [Not for Distribution in the United States of America, Canada, Australia and Japan]". 2017-07-06
Seventure Partners. (7/5/17). "Press Release: Health for Life Capital Participates in $13.2m Financing of Japanese Microbiome Leader Anaeropharma Science". Paris. 2017-07-05
Seventure Partners. (7/5/17). "Press Release: Push Doctor Raises $26.1M to Help People Live Longer". London. 2017-07-05
Servier. (6/29/17). "Press Release: Servier and Transgene Have Become Partners to Apply Viral Vectorization Technology to the Engineering of Allogenic CAR-T". 2017-06-29
Cellnovo. (6/29/17). "Press Release: Cellnovo Expands International Distribution Network". Paris. 2017-06-29
Cellectis S.A.. (6/28/17). "Press Release: Cellectis Appoints Rainer Boehm, M.D. and Hervé Hoppenot to Board of Directors". New York, NY. 2017-06-28
Cellnovo. (6/28/17). "Press Release: Cellnovo Signs Expanded Agreement to Build Second Production Line with Flex". Paris. 2017-06-28
Servier. (6/27/17). "Press Release: Servier Is the First French Pharmaceutical Company to Partner with Plug and Play Health & Wellness". 2017-06-27
Cellectis S.A.. (6/27/17). "Press Release: First in Human Administration of UCART123 in Cellectis’ AML Phase I Clinical Trial at Weill Cornell Medicine, NewYork-Presbyterian Hospital". New York, NY. 2017-06-27
Alma Bio Therapeutics S.A.S. (6/26/17). "Press Release: Alma Bio Therapeutics and Delphi Genetics Extend Strategic Alliance on Plasmid DNA Drugs". Lyon & Charleroi. 2017-06-26
Cellectis S.A.. (6/23/17). "Press Release: Calyxt Files Registration Statement for Proposed Initial Public Offering". Brisbane. 2017-06-23
Genfit S.A.. (6/23/17). "Press Release: Genfit Reaches a Critical Milestone towards the Development of a Non-invasive In Vitro Diagnostic (IVD) Test for NASH". Lille & Cambridge, MA. 2017-06-23
Novacyt S.A.. (6/20/17). "Press Release: Novacyt Successfully Completes €3.0M Fundraising". Paris & Cambridge. 2017-06-20
Cerenis Therapeutics S.A.. (6/20/17). "Press Release: Bpifrance Supports the Clinical Development of CER-209 in NAFLD /NASH with a €0.75 Million Payment for Innovation". Toulouse & Ann Arbor, MI. 2017-06-20
TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne. 2017-06-19
Genomic Vision S.A.. (6/19/17). "Press Release: Genomic Vision Inks Chinese Distribution Deal with APG Bio Ltd". Bagneux. 2017-06-19
Biophytis S.A.. (6/15/17). "Press Release: Biophytis Selects SGS Life Science Services to Conduct MACA-PK, Clinical Study of Macuneos in Dry AMD". Paris. 2017-06-15
CiToxLab. (6/15/17). "Press Release: CiToxLab and KaLy-Cell Join Forces to Offer in vitro and ex vivo Testing for Hepatotoxicity and Metabolism". Evreux & Plobsheim. 2017-06-15
Abivax S.A.. (6/12/17). "Press Release: Abivax to Receive €390,000 from Bpifrance for the Development of Its Ebola Hyperimmune Candidate". Paris. 2017-06-12
Leman Instruments SAS. (6/9/17). "Press Release: Leman Instruments Introduces New Family of High Purity Oxygen Generators. OXYSTATION 20 LC and OXYSTATION 40LC Instruments Now Available". Archamps. 2017-06-09
Innate Pharma S.A.. (6/2/17). "Press Release: Innate Pharma Strenghtens Its Proprietary Pipeline with the Acquisition of anti-C5aR, a First-in-class Clinical-stage Antibody from Novo Nordisk A/S". Marseille. 2017-06-02
Biocorp. (5/29/17). "Press Release: Biocorp Signs an Industrialization Contract with Virbac". Issoire. 2017-05-29
Medicen Paris Region. (5/23/17). "Press Release: French Tech Tour Healthcare Israel. Seven Start-ups Assess their Business Potential with Business France, Bpifrance and Medicen Paris Region". Paris. 2017-05-23
Genomic Vision S.A.. (5/23/17). "Press Release: Genomic Vision to Enter into Technological Collaboration with AstraZeneca in Oncology". Bagneux. 2017-05-23
Sanofi S.A.. (5/19/17). "Press Release: Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar". Paris. 2017-05-19
Anagenesis Biotechnologies. (5/18/17). "Press Release: Anagenesis Biotechnologies Announces Strategic Research Agreement with Boehringer Ingelheim to Discover Drugs for Chronic Muscle Diseases". Illkirch Graffenstaden. 2017-05-18
Robocath S.A.S.. (5/18/17). "Press Release: Robocath Raises €4.7 million ($5.2M) to Market Its First Medical Robotic Platform, R-one, in 2018". Rouen. 2017-05-18
Theradiag S.A.. (5/12/17). "Press Release: Successful Capital Increase, Raising €4 Million [This press release must not be disseminated, published or distributed, directly or indirectly, in the United States, Canada, Australia or Japan]". Croissy-Beaubou 2017-05-12
AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris. 2017-05-12
Enyo Pharma S.A.. (5/10/17). "Press Release: Enyo Pharma Strengthens Its Business Team to Support International Growth". Lyon. 2017-05-10
Cellectis S.A.. (5/9/17). "Press Release: Cellectis Reports 1st Quarter 2017 Financial Results". New York, NY. 2017-05-09
Eurofins Scientific. (5/9/17). "Press Release: Eurofins Strengthens Its Clinical Diagnostic Footprint in France with the Acquisition of 4 Laboratories Year to Date". 2017-05-09
Vivet Therapeutics S.A.S.. (5/4/17). "Press Release: Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases". Paris. 2017-05-04
Universal Medica Group. (5/3/17). "Press Release: Acquisition of EuroPharma by Universal Medica Group". 2017-05-03
TxCell S.A.. (5/2/17). "Press Release: TxCell and Inserm Collaborate to Develop New CAR-Tregs in Transplantation and Multiple Sclerosis". Valbonne & Nantes. 2017-05-02
next pagenext page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUK] – The Business Web Portal 600x80px

» top